Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intra-articular botulinum neurotoxin, hyaluronic acid, dextrose prolotherapy, and physical therapy in knee osteoarthritis
IRCT20181217042028N2Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of neuronox, hyaluronic acid and dextrose in knee osteoarthritis (OA) (4 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Pain severity based on Visual Analogue Scale at 3 months. Started Jun 2018; status: completed.
02
Drugs
neuronoxhyaluronic aciddextrose
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20181217042028N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181217042028N2.